Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current and future strategies for treatment of glioma.

Literature DB >> 27085859

Current and future strategies for treatment of glioma.

Nancy Ann Oberheim Bush¹, Susan M Chang², Mitchel S Berger³.

Abstract

Gliomas are one of the most common types of primary brain tumors and have remained particularly challenging to treat. This review illustrates a multidisciplinary approach to the treatment of glioma and glioblastoma. We will review current advances in surgical approaches, novel imaging techniques, advanced molecular characterization of tumors and translational efforts for treatment. We will focus on current clinical trials as well as the pursuit of personalized or precision therapy. We will also comment on the importance of both quality of life of our patients and their care givers.

Entities: Disease Species

Keywords: Glioblastoma; Glioma; Pharmacology; Quality of life; Review; Stem cell; Targeted therapy; Treatment

Mesh：

Year: 2016 PMID： 27085859 DOI： 10.1007/s10143-016-0709-8

Source DB: PubMed Journal: Neurosurg Rev ISSN： 0344-5607 Impact factor: 3.042

83 in total

1. Evoked-cerebral blood oxygenation changes in false-negative activations in BOLD contrast functional MRI of patients with brain tumors.

Authors: Norio Fujiwara; Kaoru Sakatani; Yoichi Katayama; Yoshihiro Murata; Tetsuya Hoshino; Chikashi Fukaya; Takamitsu Yamamoto
Journal: Neuroimage Date: 2004-04 Impact factor: 6.556

Review 2. Convection-enhanced delivery for the treatment of glioblastoma.

Authors: Michael A Vogelbaum; Manish K Aghi
Journal: Neuro Oncol Date: 2015-03 Impact factor: 12.300

Review 3. Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Authors: Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Kyrre E Emblem; Ovidiu Andronesi; Bruce Rosen
Journal: Cancer Res Date: 2014-09-01 Impact factor: 12.701

4. Functional MRI and 18F FDG-positron emission tomography for presurgical planning: comparison with electrical cortical stimulation.

Authors: T Krings; M Schreckenberger; V Rohde; U Spetzger; O Sabri; M H T Reinges; F J Hans; P T Meyer; W Möller-Hartmann; J M Gilsbach; U Buell; A Thron
Journal: Acta Neurochir (Wien) Date: 2002-09 Impact factor: 2.216

5. Chromosome 7p11.2 (EGFR) variation influences glioma risk.

Authors: Marc Sanson; Fay J Hosking; Sanjay Shete; Diana Zelenika; Sara E Dobbins; Yussanne Ma; Victor Enciso-Mora; Ahmed Idbaih; Jean-Yves Delattre; Khe Hoang-Xuan; Yannick Marie; Blandine Boisselier; Catherine Carpentier; Xiao-Wei Wang; Anna Luisa Di Stefano; Marianne Labussière; Konstantinos Gousias; Johannes Schramm; Anne Boland; Doris Lechner; Ivo Gut; Georgina Armstrong; Yanhong Liu; Robert Yu; Ching Lau; Maria Chiara Di Bernardo; Lindsay B Robertson; Kenneth Muir; Sarah Hepworth; Anthony Swerdlow; Minouk J Schoemaker; H-Erich Wichmann; Martina Müller; Stefan Schreiber; Andre Franke; Susanne Moebus; Lewin Eisele; Asta Försti; Kari Hemminki; Mark Lathrop; Melissa Bondy; Richard S Houlston; Matthias Simon
Journal: Hum Mol Genet Date: 2011-04-29 Impact factor: 6.150

6. Magnetic source imaging supports clinical decision making in glioma patients.

Authors: O Ganslandt; M Buchfelder; P Hastreiter; P Grummich; R Fahlbusch; C Nimsky
Journal: Clin Neurol Neurosurg Date: 2004-12 Impact factor: 1.876

7. A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors: Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal: N Engl J Med Date: 2014-02-20 Impact factor: 91.245

8. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors: Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544

9. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors: Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal: J Neurosurg Date: 2009-01 Impact factor: 5.115

10. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors: Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal: Science Date: 2013-04-04 Impact factor: 47.728

160 in total

Review 1. Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma.

Authors: Sarah Ironside; Sunit Das; Arjun Sahgal; Claire Moroney; Todd Mainprize; James R Perry
Journal: Curr Treat Options Oncol Date: 2017-10-27

2. EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis.

Authors: Shenbo Chen; Liangwang Yang; Zhengzheng Li; Shenghua Zhuo; Bo Yan; Zhaoteng Zhang; Jinben Zhang; Haizhong Feng; Kun Yang
Journal: Am J Transl Res Date: 2021-06-15 Impact factor: 4.060

3. LncRNA MACC1-AS1/MACC1 enhances the progression of glioma via regulating metabolic plasticity.

Authors: Dahai Zheng; Daliang Che; Famu Lin; Xiang Wang; Lenian Lu; Jianmin Chen; Xiaobing Xu
Journal: Cell Cycle Date: 2020-08-20 Impact factor: 4.534

4. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.

Authors: Diamanto Lazari; George A Alexiou; Georgios S Markopoulos; Evrysthenis Vartholomatos; Entela Hodaj; Ieremias Chousidis; Ioannis Leonardos; Vasiliki Galani; Athanasios P Kyritsis
Journal: J Neurooncol Date: 2017-04-01 Impact factor: 4.130

Review 5. Role of Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme.

Authors: Vishal Jindal
Journal: Mol Neurobiol Date: 2018-03-09 Impact factor: 5.590

6. Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.

Authors: Marina Martínez-Carmona; Quy P Ho; Jérémy Morand; Ana García; Enrique Ortega; Luiza C S Erthal; Eduardo Ruiz-Hernandez; M Dolores Santana; José Ruiz; Maria Vallet-Regí; Yurii K Gun'ko
Journal: Inorg Chem Date: 2020-07-06 Impact factor: 5.165

7. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.

Authors: Spyros Darmanis; Steven A Sloan; Derek Croote; Marco Mignardi; Sophia Chernikova; Peyman Samghababi; Ye Zhang; Norma Neff; Mark Kowarsky; Christine Caneda; Gordon Li; Steven D Chang; Ian David Connolly; Yingmei Li; Ben A Barres; Melanie Hayden Gephart; Stephen R Quake
Journal: Cell Rep Date: 2017-10-31 Impact factor: 9.423

8. Supratotal resection in glioma: a systematic review.

Authors: Charles N de Leeuw; Michael A Vogelbaum
Journal: Neuro Oncol Date: 2019-02-14 Impact factor: 12.300

9. The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.

Authors: Sayantan Deb; Arjun Vivek Pendharkar; Matthew K Schoen; Sean Altekruse; John Ratliff; Atman Desai
Journal: J Neurooncol Date: 2017-03-03 Impact factor: 4.130

10. Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.

Authors: Javier E Villanueva-Meyer; Seunggu J Han; Soonmee Cha; Nicholas A Butowski
Journal: J Neurooncol Date: 2017-05-31 Impact factor: 4.130